Revance Therapeutics Inc. buy michaelkr
Start price
09.12.24
/
50%
€3.66
Target price
09.12.25
-
Performance (%)
-19.67%
End price
22.12.24
€2.94
Summary
This prediction ended on 22.12.24 with a price of €2.94. The prediction for Revance Therapeutics Inc. disappointed with a performance of -19.67%. michaelkr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.598% | 5.040% | 3.870% |
| iShares Nasdaq 100 | 3.742% | 14.947% | 36.139% |
| iShares Nikkei 225® | 3.736% | 13.892% | 43.808% |
| iShares S&P 500 | 1.816% | 8.879% | 25.510% |
Comments by michaelkr for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.